Whats New

We need your help with our major new survey

Please help us by completing our major new survey on peoples experience of being diagnosed with a condition that needs you to take an anticoagulant, and how you feel about the anticoagulation service that you have received. Whether you take warfarin, apixaban, dabigatran or rivaroxaban we need to hear from you. The survey is completely anonymous. Thank you for your help. Click on the heading above and then click on to the link that you will see.

Read more »

New anticoagulation e-learning programme from the British Journal of Cardiology

‘Understanding anticoagulation’ is a new modular e-learning programme from the British Journal of Cardiology (BJC). The programme has been developed for health care professionals (HCPs) and can be accessed free at www.bjcardio.co.uk/learning. Click on heading above and click on the link

Read more »

Development of new oral anticoagulant for patients with Prosthetic Heart Valves or Chronic Renal Dysfunction

A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction

Read more »

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

A Resource pack for commissioners of anticoagulation services in the UK Read or download the resource pack from the publications section of the site.

Read more »

Sign the E-petition to get free prescriptions for people on long term anticoagulation therapy.

The cost of prescription charges in England will rise by 20p to £7.85 from 1 April In other parts of the UK prescriptions are free. Sign the E-petition to get free prescriptions for people on long term anticoagulation therapy. http://epetitions.direct.gov.uk/petitions/46432

Read more »

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. NICE guidance 275

The National Institute for Health and Clinical Excellence has issued guidance that Apixaban is recommended as an option for preventing stroke and systemic embolism within its marketing authorisation, that is, in people with nonvalvular atrial fibrillation with one or more risk factors such as: prior stroke or transient ischaemic attack age 75 years or older hypertension diabetes mellitus symptomatic heart failure.

Read more »

Rivaroxaban accepted in Scotland for treatment of Pulmonary Embolism

Xarelto® (rivaroxaban) has been accepted by the Scottish Medicines Consortium (SMC) for the treatment of pulmonary embolism (PE), and prevention of recurrent deep vein thrombosis (DVT) and PE in adults.

Read more »

Xarelto® (rivaroxaban) for the treatment of pulmonary embolism (PE) and the prevention of recurrent deep vein thrombosis (DVT) and PE in adults.

The total cost to the NHS (direct and indirect) of managing DVT and PE is estimated to be £640 million. In 2013, there are expected to be 52,600 cases of DVT and 43,000 cases of PE in the UK. “Each year over 25,000 people in England die from venous thromboembolism (VTE) contracted in hospital. Approximately 1 in 3 patients who suffer apulmonary embolism die within 3 months and, concerningly, PE remains a leading cause of hospital death

Read more »

Obesity triggers AF in fertile women. Atrial fibrillation is rare in young, healthy individuals. However, it is unknown whether obesity increases the risk of atrial fibrillation in young people without other risk factors.

Atrial fibrillation is rare in young, healthy individuals and precipitating factors remain controversial. A growing body of evidence suggests that genetic predisposition, inflammation, obstructive sleep apnea, excessive alcohol consumption, and excessive physical exercise may cause atrial fibrillation in these individuals. However, it is unknown whether obesity increases the risk of atrial fibrillation in young people without other risk factors.

Read more »

Information for patients taking warfarin

Have you recently been prescribed warfarin and would like more information? For a beginners guide to warfarin please watch this short video. Video kindly created by Southampton University NHS Hospital Foundation Trust

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space